Skip to main content
Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
5.72
+0.25 (4.57%)
At close: Apr 28, 2026, 4:00 PM EDT
5.81
+0.09 (1.57%)
Pre-market: Apr 29, 2026, 7:05 AM EDT

Q32 Bio Revenue

In the year 2025, Q32 Bio had annual revenue of $53.74M. Q32 Bio had revenue of $53.74M in the quarter ending December 31, 2025.

Revenue (ttm)
$53.74M
Revenue Growth
n/a
P/S Ratio
1.56
Revenue / Employee
$2,239,042
Employees
24
Market Cap
83.68M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202553.74M--
Dec 31, 2024---
Dec 31, 2023-6.65M-13.30M-200.00%
Dec 31, 20226.65M--
Dec 31, 2021---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Champions Oncology 57.95M
Gossamer Bio 48.47M
Sangamo Therapeutics 39.55M
Alterity Therapeutics 4.43M
eXoZymes -700.00
Revenue Rankings

QTTB News

More News